Reckitt Benckiser pays $1.4 billion in opioid settlement

LONDON — Consumer products company Reckitt Benckiser says it will pay $1.4 billion to resolve U.S. investigations into the marketing of an anti-addiction drug by a subsidiary.

The company said Thursday it reached agreements with the U.S. Department of Justice and the Federal Trade Commission.

The government alleged that an ex-Reckitt subsidiary sought to increase prescriptions for Suboxone Film by deceiving health care providers into believing the drug was safer than other opioid addiction treatments.

Suboxone Film was marketed by RB's former prescription business Indivior, which was spun off in 2014.

The company says it "acted lawfully at all times and expressly denies all allegations that it engaged in any wrongful conduct" but the settlement was in the best interest of RB and shareholders.

It said the settlement would prevent uncertainty and distraction from continued investigations.

Must Read

Fans mourn pop's George Michael as charities...

Dec 26, 2016

Fans are mourning the death of pop star George Michael as British charities praise his generosity

Duchess of Cambridge meets families at children's...

Jan 24, 2017

The Duchess of Cambridge has paid an emotional visit to a children's hospice in a village northeast...

Trump state visit plans put queen in 'difficult...

Jan 31, 2017

The British government's decision to invite President Donald Trump for a state visit, one of the...

AP Exclusive: Unusual Magritte could hit $17.5M...

Feb 6, 2017

One of the largest and most unusual paintings by Surrealist master Rene Magritte is going up for...

Vibrant Tate show traces David Hockney's artistic...

Feb 6, 2017

It's not often an artist finds himself occupying 12 rooms of London's leading museum of British art...

Sign up now!